
|Articles|March 1, 2011
- Pharmaceutical Executive-03-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2011
Castellani Takes Charge at PhRMA
Advertisement
Articles in this issue
about 15 years ago
PICASSO—Truly a Work of Artabout 15 years ago
The Netherlands: Innovation through Collaborationabout 15 years ago
Restructured for Successabout 15 years ago
The "Other" Innovationabout 15 years ago
Where have all the Scientists Gone?about 15 years ago
Making Sense of Market Chaosabout 15 years ago
Pharm Exec's Seventh Annual Media Auditabout 15 years ago
New Tools Track Safety, Value in Medicineabout 15 years ago
A Rule of Thumb Gets Shot Downabout 15 years ago
John Castellani: Industry's Level Bet on a Dizzying FutureAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




